Rani Therapeutics Holdings, Inc. SEC filings RANI
Rani Therapeutics Holdings, Inc. has 380 filings in SEC EDGAR's recent list, going back to Apr 27, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 4, 2026 | Aug 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 28, 2026 |
| 8-K |
Current report
Other events
|
May 27, 2026 | May 26, 2026 |
| 8-K |
Current report
Results of operations, Listing notice, Officer or director change
|
May 15, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Agreement ended, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jan 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 27, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 17, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Listing notice
|
Jun 26, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2025 | May 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 20, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Listing notice
|
May 6, 2025 | May 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 9, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Other events
|
Oct 16, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Auditor change
|
Sep 11, 2024 | Sep 10, 2024 |
| 8-K | Current report | Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jul 23, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 12, 2024 | Jul 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 24, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2023 | Dec 16, 2023 |
| 8-K |
Current report
Other events
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Exit or restructuring costs
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Other events
|
Oct 25, 2023 | Oct 25, 2023 |
| 8-K |
Current report
Other events
|
Sep 7, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2023 | May 25, 2023 |
| 8-K | Current report | May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Other events
|
Apr 5, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 9, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 5, 2023 | Jan 5, 2023 |
| 8-K |
Current report
New debt
|
Dec 30, 2022 | Dec 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 6, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Material agreement
|
Aug 25, 2022 | Aug 24, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2022 | May 25, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2022 | Mar 29, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 23, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 23, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2022 | Jan 2, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2021 | Sep 29, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 13, 2021 | Sep 13, 2021 |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RANI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- San Jose, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1856725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.